Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis
暂无分享,去创建一个
Jimmy D Bell | A. Hingorani | S. Neubauer | Elizabeth Louise Thomas | H. Hemingway | Riyaz S. Patel | H. Yaghootkar | R. Banerjee | J. McGonigle | C. Parisinos | H. Wilman | M. Kelly | R. Nicholls | R. Patel
[1] B. Neuschwander‐Tetri,et al. Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum , 2019, Hepatology.
[2] Sarah E. Williams,et al. A schizophrenia risk locus alters brain metal transport and plasma glycosylation , 2019, bioRxiv.
[3] M. Arumugam,et al. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration , 2019, Journal of hepatology.
[4] A. Dehghan,et al. Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study , 2019, Journal of the American Heart Association.
[5] Roger Williams,et al. Alcohol policy in the UK: where next? , 2019, The Lancet.
[6] F. Tacke,et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.
[7] J. Trotter,et al. NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis , 2019, Hepatology.
[8] Mary E. Haas,et al. A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease , 2019, bioRxiv.
[9] Z. Younossi. Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.
[10] A. Herlihy,et al. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver , 2018, PLoS ONE.
[11] Laura J. Scott,et al. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals , 2018, Nature Genetics.
[12] Jimmy D Bell,et al. Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension , 2018, Diabetes.
[13] C. Cruchaga,et al. A missense variant in SLC39A8 is associated with severe idiopathic scoliosis , 2018, Nature Communications.
[14] D. Nebert,et al. Hepatic ZIP8 deficiency is associated with disrupted selenium homeostasis, liver pathology, and tumor formation. , 2018, American journal of physiology. Gastrointestinal and liver physiology.
[15] J. Marchini,et al. Genome-wide association studies of brain imaging phenotypes in UK Biobank , 2018, Nature.
[16] S. Neubauer,et al. Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial , 2018, PloS one.
[17] M. Gee,et al. Magnetic resonance enterography evaluation of Crohn disease activity and mucosal healing in young patients , 2018, Pediatric Radiology.
[18] Jimmy D Bell,et al. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases , 2018, Abdominal Radiology.
[19] G. Davey Smith,et al. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians , 2018, British Medical Journal.
[20] Rachel M. Brown,et al. Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study , 2018, Scientific Reports.
[21] Dereje D. Jima,et al. A Common Allele in FGF21 Associated with Sugar Intake Is Associated with Body Shape, Lower Total Body-Fat Percentage, and Higher Blood Pressure , 2018, Cell reports.
[22] P. Visscher,et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.
[23] Mohammad R. Ostovaneh,et al. Association of Liver Fibrosis With Cardiovascular Diseases in the General Population: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2018, Circulation. Cardiovascular imaging.
[24] J. Costas. The highly pleiotropic gene SLC39A8 as an opportunity to gain insight into the molecular pathogenesis of schizophrenia , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[25] B. Nordestgaard,et al. Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals , 2018, European heart journal.
[26] S. Mukhopadhyay. Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14. , 2017, Neurotoxicology.
[27] Mark Hudson,et al. Guidelines on the management of abnormal liver blood tests , 2017, Gut.
[28] Michael Brady,et al. Deep Quantitative Liver Segmentation and Vessel Exclusion to Assist in Liver Assessment , 2017, MIUA.
[29] C. Minelli,et al. The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[30] F. Shidfar,et al. Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet , 2017, Biological Trace Element Research.
[31] Tao Wang,et al. Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity , 2017, The Journal of clinical investigation.
[32] M. Robson,et al. Multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease severity , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[33] Stefan Neubauer,et al. Interobserver Variability in Histologic Evaluation of Liver Fibrosis Using Categorical and Quantitative Scores , 2017, American journal of clinical pathology.
[34] T. Card,et al. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. , 2017, The lancet. Gastroenterology & hepatology.
[35] Stefan Neubauer,et al. Characterisation of liver fat in the UK Biobank cohort , 2017, PloS one.
[36] G. Ambler,et al. Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: A cautionary note on a promising technique. , 2017, Journal of hepatology.
[37] M. Robson,et al. Reply to: "Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: A cautionary note on a promising technique". , 2017, Journal of hepatology.
[38] Judy H. Cho,et al. A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition. , 2016, Gastroenterology.
[39] Stephen Burgess,et al. PhenoScanner: a database of human genotype–phenotype associations , 2016, Bioinform..
[40] Tom R. Gaunt,et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016, bioRxiv.
[41] Samuel E. Jones,et al. Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease , 2016, Diabetes.
[42] Matthew D. Robson,et al. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease , 2016, Journal of hepatology.
[43] Ellen M. Schmidt,et al. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk , 2016, Nature Communications.
[44] Judy H. Cho,et al. A pleiotropic missense variant in SLC 39 A 8 is associated with Crohn ’ s disease and human gut microbiome composition Short Title : SLC 39 A 8 associated with CD and gut microbiome , 2016 .
[45] David M. Evans,et al. Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis , 2015, Nature Genetics.
[46] J. Danesh,et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .
[47] E. Speliotes,et al. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? , 2015, Gastroenterology.
[48] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[49] Toshiko Tanaka,et al. Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis , 2014, Nature Communications.
[50] M. Robson,et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease , 2014, Journal of hepatology.
[51] Chia-Ying Liu,et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). , 2013, Journal of the American College of Cardiology.
[52] Nicholette D. Palmer,et al. Characterization of european ancestry nonalcoholic fatty liver disease‐associated variants in individuals of african and hispanic descent , 2013, Hepatology.
[53] B. Pierce,et al. Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators , 2013, American journal of epidemiology.
[54] P. Matthews,et al. Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches , 2013, Journal of Cardiovascular Magnetic Resonance.
[55] D. Nebert,et al. ZIP8 regulates host defense through zinc-mediated inhibition of NF-κB. , 2013, Cell reports.
[56] H. El‐Serag,et al. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[57] Michael Charlton,et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. , 2012, Gastroenterology.
[58] R. Wevers,et al. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. , 2012, American journal of human genetics.
[59] Christian Gieger,et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma , 2011, Nature Genetics.
[60] Udo Hoffmann,et al. Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits , 2011, PLoS genetics.
[61] Joel Z Stengel,et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.
[62] Henrik,et al. Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index , 2012 .
[63] K. Lange,et al. Prioritizing GWAS results: A review of statistical methods and recommendations for their application. , 2010, American journal of human genetics.
[64] Jie Liu,et al. Zinc supplementation reverses alcohol‐induced steatosis in mice through reactivating hepatocyte nuclear factor‐4α and peroxisome proliferator‐activated receptor‐α , 2009, Hepatology.
[65] A. Hingorani,et al. Nature's randomised trials , 2005, The Lancet.
[66] T. Coates,et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.
[67] R. Fisher,et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.
[68] C. Day,et al. Non‐alcoholic steatohepatitis: Definitions and pathogenesis , 2002, Journal of gastroenterology and hepatology.
[69] K. Fox. Hypertension and heart disease. , 1996, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[70] H. Bremer,et al. TWO CASES OF PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY , 1976, Acta paediatrica Scandinavica.
[71] Sharma,et al. Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis , 2022 .